Prudential Financial
VTVT icon

Prudential Financial’s vTv Therapeutics VTVT Stock Holding History

Prudential Financial’s Portfolio VTVT Stock Details VTVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-260
Closed -$6.79K – 2676
2022
Q4 		$6.79K Sell
260
-740
-74% -$24.5K ﹤0.01% 2586
2022
Q3 		$39K Hold
1,000
– – ﹤0.01% 2583
2022
Q2 		$30K Buy
+1,000
New +$25.6K ﹤0.01% 2619

Other funds holding VTVT

SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
V
Veritable Wilmington, Delaware $6.46B AUM 17.32% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Prudential Financial's VTVT Position: Q1 2023 in Review

Prudential Financial sold out of vTv Therapeutics (VTVT) in Q1 2023, closing a stake of 260 shares — an estimated $6.79K sold.

Prudential Financial first reported a position in VTVT in Q2 2022 and held it in 3 quarters. The position peaked at $39K in Q3 2022. 24 funds tracked by Wall St. Rank hold VTVT as of Q1 2023.

  • Prudential Financial reported no remaining vTv Therapeutics position as of Q1 2023 after selling out during the quarter.
  • Prudential Financial sold 260 vTv Therapeutics shares in Q1 2023, an estimated $6.79K.
  • Prudential Financial first reported a position in vTv Therapeutics in Q2 2022 and held it in 3 quarters.
  • Prudential Financial's vTv Therapeutics position peaked at $39K in Q3 2022.
  • 24 funds tracked by Wall St. Rank held vTv Therapeutics as of Q1 2023.

Based on Prudential Financial's 13F filing for Q1 2023, filed 12 May 2023.